Safety and effectiveness of <scp>NMDA</scp> receptor antagonists for depression: A multidisciplinary review-Reference-Cited by-同舟云学术

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review

Published:2022-06-26 Issue:7 Volume:42 Page:567-579
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Moore Thomas J.¹²^ORCID,Alami Abdallah³⁴,Alexander G. Caleb¹⁵,Mattison Donald R.³⁶⁷

Affiliation:

1. Center for Drug Safety and Effectiveness, Bloomberg School of Public Health Johns Hopkins University Baltimore Maryland USA

2. Department of Epidemiology Milken Institute School of Public Health, The George Washington University Washington District of Columbia USA

3. McLaughlin Centre for Population Health Risk Assessment University of Ottawa Ottawa Ontario Canada

4. School of Mathematics and Statistics Carleton University Ottawa Ontario Canada

5. Division of General Internal Medicine Johns Hopkins Medicine Baltimore Maryland USA

6. Department of Epidemiology and Biostatistics, Arnold School of Public Health University of South Carolina Columbia South Carolina USA

7. School of Epidemiology and Public Health University of Ottawa Ottawa Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2707

Reference51 articles.

1. Prescribing information for KETALAR (ketamine hydrochloride) Injection for Intravenous or Intramuscular Use CIII. Package insert.Par Pharmaceutical;2020.

2. Prescribing information for SPRAVATO (esketamine) Nasal Spray CIII. Package insert.Janssen Pharmaceuticals Inc.;2020.

3. European Medicines Agency.Spravato [Internet]. European Medicines Agency Web Site.2019. Cited September 24 2021.https://www.ema.europa.eu/en/medicines/human/EPAR/spravato

4. DARK Classics in Chemical Neuroscience: Phencyclidine (PCP)

5. Ketamine: A Paradigm Shift for Depression Research and Treatment

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketamine and Nitrous Oxide;Reference Module in Neuroscience and Biobehavioral Psychology;2024

2. What clinicians need to know about intranasal esketamine for treatment-resistant depression?;Australasian Psychiatry;2023-11-14

3. A synopsis of multitarget therapeutic effects of anesthetics on depression;European Journal of Pharmacology;2023-10

4. Folate and Its Significance in Depressive Disorders and Suicidality: A Comprehensive Narrative Review;Nutrients;2023-09-04

5. Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study;Neuropsychopharmacology;2023-05-12